Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?

Karisha Roopnarain; Christine Klein

doi:10.1002/mdc3.13619

Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?

Mov Disord Clin Pract. 2023 Jan 20;10(Suppl 2):S26-S31. doi: 10.1002/mdc3.13619. eCollection 2023 Aug.

Authors

Karisha Roopnarain^{1

2}, Christine Klein¹

Affiliations

¹ Institute of Neurogenetics University of Luebeck and University Hospital Schleswig-Holstein Luebeck Germany.
² Faculty of Medicine and Health Sciences Stellenbosch University Cape Town South Africa.

No abstract available

Keywords: GBA pathogenic variants; LRRK2 pathogenic variants; Parkinson's disease; Parkinson's disease genetic etiology; genetic testing for Parkinson's disease; monogenic Parkinson's disease.